Your email has been successfully added to our mailing list.

×
0.00352112676056346 1.5636944008805E-16 0.00352112676056346 0.00352112676056346 0.00352112676056346 0.00352112676056346 1.5636944008805E-16 -0.0211267605633801
Stock impact report

OncoMed Pharmaceuticals: Assessing The Prospect Of A Potential Robust Winner [Seeking Alpha]

ONCOMED PHARMACEUTICALS (OMED) 
Last oncomed pharmaceuticals earnings: 11/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: oncomed.com/invest/index.cfm
Company Research Source: Seeking Alpha
OncoMed Pharmaceuticals: Assessing The Prospect Of A Potential Robust WinnerSummaryAs a promising grower, OncoMed is leveraging on the “more shots on goal” strategy. Despite earlier missed clinical outcomes, the company is brewing stellar molecules that are approaching their binaries.Anti-TIGIT is an interesting franchise being investigated in combination with an anti-PD1. We’re most interested in navicixizumab, a multi-dimensional molecule being assessed in combination with the standard chemotherapy.If the later-stage clinical outcomes are favorable as we prognosticated, the company can become a target for acquisition. Show less Read more
Impact Snapshot
Event Time:
OMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for OMED alerts
Opt-in for
OMED alerts

from News Quantified
Opt-in for
OMED alerts

from News Quantified